The health test, called the Health+Ancestry test, will detect consumers' risk of developing conditions like Parkinson's and Alzheimer's disease, in today's bite-sized hospital and health industry news from California, Pennsylvania, Tennessee, and Utah.
- California/Utah: MyHeritage, a direct-to-consumer DNA testing company based in Israel with offices in California and Utah, announced that it will offer a genetic health test. The test, called the Health+Ancestry test, will provide 11 genetic risk reports and three polygenic risk reports, which is more than other major at-home DNA testing companies offer, according to Becker's Health IT & CEO Report. The risk reports will detect consumers' risk of developing conditions like late-onset Parkinson's disease and late-onset Alzheimer's disease. The test will sell for $199 (Park, Becker's Health IT & CIO Report, 5/21).
- Pennsylvania: Drexel University and Tower Health have signed a letter of intent to merge their physician groups to create a combined group of 735 physicians. The merger would increase options for clinical rotations for medical students and expand the organizations' "clinical footprint," according to Drexel President John Fry. The organizations have had an academic affiliation for 20 years and are currently planning to open a four-year medical school (Rappleye, Becker's Hospital Review, 5/21; Brubaker, Philadelphia Inquirer, 5/15).
- Tennessee: Bridget Perez, a patient at Vanderbilt University Medical Center, thought she wouldn't be able to see her daughter, Jaszmon, graduate from high school. Perez, who has lung disease, has been a patient at Vanderbilt for 45 days and was too sick to leave the hospital on Jaszmon's graduation day. But, Vanderbilt staff on Tuesday staged a graduation for Jaszmon so that Perez could see her daughter in her cap and gown on graduation day. "I got to graduate with my mom," Jaszmon said. "I got to walk with her, and I got to be here with her" (Sanders, WFMZ, 5/22).
Genetic testing—and 7 other technologies that could transform health care
Our new report explores the clinical technology pipeline to help health care leaders become more conversant in the major vectors of innovation, leading applications of new technologies, and the business implications for established providers. Read on to unpack the new innovation agenda.